12 results found
- Men's health month: Prostate cancer research
Prostate cancer is the most common malignancy diagnosed in New Zealand men. Ethnic disparities in outcomes are well documented for prostate cancer, and despite the fact that Māori men have lower incidence of developing prostate cancer when compared to non-Māori, Māori men have significantly higher mortality rates. "I'm developing a New Zealand-specific prostate cancer risk calculator, which accounts for the ethnic diversity of our communities." He says, "Because New Zealand lacks an organised prostate cancer screening program with dedicated monitoring and quality assurance services, like the existing breast or bowel cancer screening programs, the distribution of the prostate cancer screening pattern, though high, has been inequitable, with Māori men being significantly disadvantaged." He says, "It is so important to improve screening services for prostate cancer in New Zealand because this is frequently a manageable cancer, with timely diagnosis.
- Melanoma Awareness Week: Uniting biology and engineering for better treatment of melanoma patients
A new research study will focus on the analysis of a newly discovered signal in the blood that could be used early in cancer patients' treatment with immunotherapies, such as Keytruda, to detect whether the treatment is working for them. We believe that these tests, performed on a tiny blood sample, could become a simple and accessible aid to benefit all cancer patients and particularly overcome challenges for rural New Zealand patients. Blenkiron is in the process of establishing her new cancer biology laboratory, focusing on the analysis of extracellular vesicles, while Dr Hisey is a young investigator forging his research path into developing better tools and methods for understanding of how cancer cells talk to one another to enable their survival. On a personal level, the opportunity to spend our days developing new tools that could one day be used to improve the lives of people undergoing cancer treatment is humbling. Read more about Dr Blenkiron's AMRF funded skin cancer research here.
- Kiwi experts shining light on skin cancer
It is also the time of year when we are much more susceptible to skin cancer through sun damage. And anecdotally, this summer it is likely that people will die from what medical researcher Dr Cherie Blenkiron describes as “an uncommon form of skin cancer” – Merkel cell carcinoma (MCC). This ground-breaking work has been funded by AMRF, through support from a family fund in memory of their brother, and more of this type of funding is needed to improve outcomes for people with cancer. The research we do could be transferable to other cancers as well as significantly benefitting MCC patients in New Zealand, and around the world.”
- Striving to Improve Cancer Treatment
The first question people ask when given the news that they have cancer is usually “how long have I got?”. If they have a GBM brain cancer the answer can be even more devastating. Having seen her aunt’s battle with cancer rob her of her quality of life in just a few months after detection, Zoe is striving to improve outcomes for GBM patients and is making significant in-roads early in her career. This is quite rapid compared to a lot of other types of cancers,” Zoe reveals.
- Legacy is... medical research now
Click to watch video from A/Prof Jane Alsweiler about a $2 treatment that can save babies' brains Click to learn about cancer research in prostate, skin, brain and more Click to learn more and watch video about dementia research from Dr Brigid Ryan And more!
- Scholarships and Fellowships help start researchers off strongly
dently after Stroke Tool" Dr Nikki Earle, Department of Medicine, The University of Auckland (left, middle image) Douglas Goodfellow Postdoctoral Fellowship "Multi-omics for ACS: Multi-omics and biomarkers to personalise risk prediction and therapy in acute coronary syndromes" Dr William Schierding, The Liggins Institute (left, lower image) Douglas Goodfellow Postdoctoral Fellowship "3D genome dysregulation: Systematic interpretation of noncoding regulatory (enhancer) mutations driving cancer onset, progression, and treatment" "I'm extremely grateful to the charitable donors who have made this work possible and I hope they, and their loved ones will benefit from my work." - Dr Tim Angeli, 2016 Fellowship recipient 2020 Doctoral Scholars Ms Sarah Kember, Department of Psychology, Massey University (left, top image) "Maternal mental health and vaccination behaviours in Aotearoa: Population immunity in Aotearoa, the relationship between perinatal psychological distress and va
- AMRF Newsletter - Autumn 2019
In this issue: Gastroparesis, gastrointestinal disorders and endoscopic imaging; personalised medicine for breast cancer patients; dermatologist's up-skilling in skin cancer surgery for cutaneous lymphoma Click image below to view or download the PDF file.
- AMRF Newsletter - Spring 2018
Auckland Medical Research Foundation's latest success stories and awarded grants.This medical research news is supported by charitable donors and includes historical goitre research in the Nepalese Himalayas and stories of family legacies for human health research in skin cancer, melanoma, neuroscience and more.
- AMRF Newsletter - Spring 2019
In this issue you’ll see research highlights including: Cancer researcher Dr Chang Ho Yoon and the work he’s doing to bring Artificial Intelligence to healthcare and improve the patient experience; Recent awards for presentations and posters by our researchers of the future; And how support from people like you is helping to make a life-changing difference in medical research.
- AMRF pledges $500,000 for immediate projects
This is over and above the Foundation’s average of more than $3.5 million – granted annually for a wide range of medical research each year – including dementia, cancers, stroke treatments, antibiotic development, heart health and youth mental health.